Managing COVID-19 in four small countries: Initial response to the pandemic in San Marino, Montenegro, Malta and Cyprus.


Journal

Health policy (Amsterdam, Netherlands)
ISSN: 1872-6054
Titre abrégé: Health Policy
Pays: Ireland
ID NLM: 8409431

Informations de publication

Date de publication:
04 2022
Historique:
received: 04 11 2020
revised: 12 08 2021
accepted: 16 01 2022
pubmed: 2 2 2022
medline: 8 4 2022
entrez: 1 2 2022
Statut: ppublish

Résumé

The aim of this paper is to compare the impact of the COVID-19 pandemic on four small countries in the southern half of Europe with similar public health systems: San Marino, Montenegro, Malta and Cyprus, the latter two being island states. There are advantages and disadvantages in being a small nation amidst this crisis. The centralized public health administration means that small countries are faster at adapting as they learn and evolve on a weekly basis. However, small countries tend to be dependent on their bigger neighbours, and the networks they belong to, for trade, food, medical supplies as well as policies. The risk threshold taken by a small country for the transition strategy has to be less than that taken by a bigger country because if things go wrong in a border region, there is less resilience in a small country, with immediate impact on the whole country. The blow to the tourism industry, which plays a main role especially in small countries, negatively impacted the economy, and it has been a feat to reach a balance between allowing the flow of inbound tourists and keeping the local infection rates under control.

Identifiants

pubmed: 35101288
pii: S0168-8510(22)00017-3
doi: 10.1016/j.healthpol.2022.01.008
pmc: PMC8776625
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

281-286

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Références

BMJ. 2021 Jan 22;372:n83
pubmed: 33483336
Viruses. 2020 Jul 20;12(7):
pubmed: 32698418
Z Gesundh Wiss. 2022;30(2):459-464
pubmed: 32837836
ACS Nano. 2020 Oct 27;14(10):12522-12537
pubmed: 33034449
Int J Risk Saf Med. 2020;31(3):121-130
pubmed: 32597822
J Community Health. 2021 Jun;46(3):618-625
pubmed: 32936428
Age Ageing. 2021 Jan 8;50(1):7-10
pubmed: 32725156
J Med Internet Res. 2020 Jun 26;22(6):e19659
pubmed: 32558655
Financ Innov. 2020;6(1):40
pubmed: 35024265
Lancet. 2020 Apr 4;395(10230):1096-1099
pubmed: 32203693
PLoS One. 2020 Oct 15;15(10):e0239389
pubmed: 33057434

Auteurs

Neville Calleja (N)

Department of Public Health, Faculty of Medicine and Surgery, University of Malta, Malta. Electronic address: neville.calleja@um.edu.mt.

Andrea Gualtieri (A)

Dipartimento di Sanita Pubblica della AUSL Romagna-Cesena, Italy. Electronic address: andrea.gualtieri@auslromagna.it.

Natasa Terzic (N)

Centre for Health System Development, Institute of Public Health, Montenegro. Electronic address: natasa.terzic@ijzcg.me.

Vasos Scoutellas (V)

Health Monitoring Unit, Ministry of Health, Cyprus. Electronic address: VScoutellas@mphs.moh.gov.cy.

Jean Calleja-Agius (J)

Head of Department of Anatomy, Faculty of Medicine and Surgery Room 413, Biomedical Sciences Building & Centre for Molecular Medicine and Biobanking University of Malta, Msida MSD2080, Malta. Electronic address: jean.calleja-agius@um.edu.mt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH